Hasil Pencarian - Igor Puzanov

Perbaiki Hasil
  1. 1
    Anti-IL6R role in treatment of COVID-19-related ARDS

    Anti-IL6R role in treatment of COVID-19-related ARDS oleh Franco Maria Buonaguro, Igor Puzanov, Paolo Antonio Ascierto

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Editorial: Advancements in Molecular Diagnosis and Treatment of Melanoma

    Editorial: Advancements in Molecular Diagnosis and Treatment of Melanoma oleh Giuseppe Palmieri, Igor Puzanov, Daniela Massi, Paolo Antonio Ascierto

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors

    Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors oleh Samra Turajlic, Igor Puzanov, Paul C Lorigan, Benjamin Switzer

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Cardiotoxic profiles of CAR-T therapy and bispecific T-cell engagers in hematological cancers

    Cardiotoxic profiles of CAR-T therapy and bispecific T-cell engagers in hematological cancers oleh Badri Karthikeyan, Sunitha Shyam Sunder, Igor Puzanov, Scott H. Olejniczak, Saraswati Pokharel, Umesh C. Sharma

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    The Great Debate at “Melanoma Bridge”, Napoli, December 2nd, 2017

    The Great Debate at “Melanoma Bridge”, Napoli, December 2nd, 2017 oleh Paolo A. Ascierto, Corrado Caracò, Jeffrey E. Gershenwald, Omid Hamid, Merrick Ross, Ryan J. Sullivan, Igor Puzanov

    Diterbitkan 2018-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    2178 Drug development core facilitates institutional collaboration and translational science innovation

    2178 Drug development core facilitates institutional collaboration and translational science innovation oleh Gene Morse, Igor Puzanov, Andrei Gudkov, Robin DiFrancesco, William Jusko, Marc Ernstoff, James Mohler, Timothy Murphy, Robert Bies

    Diterbitkan 2018-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials

    Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials oleh Howard L. Kaufman, Robert H. I. Andtbacka, Frances A. Collichio, Michael Wolf, Zhongyun Zhao, Mark Shilkrut, Igor Puzanov, Merrick Ross

    Diterbitkan 2017-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy

    Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy oleh Sarah Nikiforow, John Haanen, Igor Puzanov, Rodabe Amaria, Amod Sarnaik, Marcus O Butler, Michael R Bishop, Adam J Schoenfeld, Krishna Komanduri

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    The “Great Debate” at Immunotherapy Bridge 2022, Naples, November 30th–December 1st, 2022

    The “Great Debate” at Immunotherapy Bridge 2022, Naples, November 30th–December 1st, 2022 oleh Paolo A. Ascierto, Renier Brentjens, Samir N. Khleif, Kunle Odunsi, Katayoun Rezvani, Marco Ruella, Ryan J. Sullivan, Bernard A. Fox, Igor Puzanov

    Diterbitkan 2023-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature

    Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature oleh Nikhil Agrawal, Arjun Khunger, Pankit Vachhani, Teresa A. Colvin, Alexander Hattoum, Edward Spangenthal, Anne B. Curtis, Grace K. Dy, Marc S. Ernstoff, Igor Puzanov

    Diterbitkan 2019-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    The great debate at “Melanoma Bridge 2018”, Naples, December 1st, 2018

    The great debate at “Melanoma Bridge 2018”, Naples, December 1st, 2018 oleh Paolo A. Ascierto, Paolo Bruzzi, Alexander Eggermont, Omid Hamid, Hussein A. Tawbi, Alexander van Akkooi, Alessandro Testori, Corrado Caracò, Igor Puzanov, Francesco Perrone

    Diterbitkan 2019-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    The “Great Debate” at Immunotherapy Bridge 2020, December 3rd, 2020

    The “Great Debate” at Immunotherapy Bridge 2020, December 3rd, 2020 oleh Paolo A. Ascierto, Joshua Brody, Lisa H. Butterfield, Olivera J. Finn, John Goldberg, Francesco Perrone, Ryan J. Sullivan, Bernard A. Fox, Patrick Hwu, Igor Puzanov

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    512 Phase I dose escalation of KD033, a PDL1-IL15 bispecific molecule, in metastatic and advanced solid tumors

    512 Phase I dose escalation of KD033, a PDL1-IL15 bispecific molecule, in metastatic and advanced solid tumors oleh Igor Puzanov, Jason Luke, Anthony Olszanski, Dan Lu, Stella Martomo, Jeegar Patel, Christos Fountzilas, Lee Rosen, Adrian Hackett, Olivier Schueller, David Eiznhamer, Alessandro Mora, Miranda Ross

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    The great debate at “Immunotherapy Bridge 2018”, Naples, November 29th, 2018

    The great debate at “Immunotherapy Bridge 2018”, Naples, November 29th, 2018 oleh Paolo A. Ascierto, Lisa H. Butterfield, Sandra Demaria, Robert L. Ferris, Gordon J. Freeman, Roger S. Lo, Alberto Mantovani, Paul Nathan, Omid Hamid, Katerina Politi, Igor Puzanov

    Diterbitkan 2019-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction

    Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction oleh Igor Puzanov, Suthee Rapisuwon, Leora Horn, Bridgette A. Kanz, Megan H. Pollack, Romany Johnpulle, Alicia Morgans, Jeffrey A. Sosman, R. Martin Conry, Zeynep Eroglu, Douglas B. Johnson

    Diterbitkan 2016-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Use of artificial intelligence chatbots in clinical management of immune-related adverse events

    Use of artificial intelligence chatbots in clinical management of immune-related adverse events oleh Jarushka Naidoo, Igor Puzanov, Paolo A Ascierto, Marc S Ernstoff, Douglas B Johnson, Fei Ye, Mitchell S von Itzstein, David E Gerber, Benjamin Switzer, Aliyah Pabani, Hannah Burnette, Run Fan

    Diterbitkan 2024-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    The Great Debate at “Melanoma Bridge”, Naples, December 7th, 2019

    The Great Debate at “Melanoma Bridge”, Naples, December 7th, 2019 oleh Paolo A. Ascierto, Sanjiv S. Agarwala, Alexander Eggermont, Jeffrey E. Gershenwald, Jean-Jacques Grob, Omid Hamid, Olivier Michielin, Michael Postow, Igor Puzanov, Hassane M. Zarour, Corrado Caracò, Alessandro Testori

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    The “Great Debate” at Immunotherapy Bridge 2021, December 1st–2nd, 2021

    The “Great Debate” at Immunotherapy Bridge 2021, December 1st–2nd, 2021 oleh Paolo A. Ascierto, Lisa H. Butterfield, Olivera J. Finn, Andrew Futreal, Omid Hamid, Theresa LaVallee, Michael A. Postow, Igor Puzanov, Jeffrey Sosman, Bernard A. Fox, Patrick Hwu

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    701 Activating CD73 on B cells as a target for immunotherapy of COVID-19 and viral associated cancers: clinical activity in human papilloma virus positive (HPV) head and neck squamous cell cancers (HNSCC)

    701 Activating CD73 on B cells as a target for immunotherapy of COVID-19 and viral associated cancers: clinical activity in human papilloma virus positive (HPV) head and neck squam... oleh Igor Puzanov, Richard Miller, Jason Luke, Jeffrey Sosman, Thomas Marron, Brett Hughes, Abhishek Tripathi, Mehrdad Mobasher, Craig Hill, Shenshen Hu, Suresh Mahabhashyam, Kristen Marrone, Jaime Merchan, James Janc, Jenny Rudnick

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    433 Talimogene laherparepvec (T-VEC) in combination with ipilimumab (IPI) versus IPI alone for advanced melanoma: 4-year interim analysis of a randomized, open-label, phase 2 trial

    433 Talimogene laherparepvec (T-VEC) in combination with ipilimumab (IPI) versus IPI alone for advanced melanoma: 4-year interim analysis of a randomized, open-label, phase 2 trial... oleh Min Yi, Celeste Lebbe, Parminder Singh, Omid Hamid, Jason Chesney, Igor Puzanov, Mohammed Milhem, Merrick Ross, Janice Mehnert, Theodore Logan, Philip Friedlander, Frances Collichio, Claus Garbe, John Glaspy, Axel Hauschild, Wendy Snyder

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: